Skip to main content

Biochemical and Molecular Chitotriosidase Profiles in Patients with Gaucher Disease Type 1 in Minas Gerais, Brazil: New Mutation in CHIT1 Gene

  • Research Report
  • Chapter
  • First Online:
JIMD Reports – Case and Research Reports, 2012/6

Abstract

Chitotriosidase (ChT) is a human chitinase secreted by activated macrophages and its activity is used in therapeutic monitoring of Gaucher disease (GD), the most common lysosomal storage disease. About 6% of the population is homozygous for a duplication of 24 bp in exon 11 of the CHIT1 gene (dup24), which is the main polymorphism that results in the absence of ChT. As ChT enzyme activity can be used as a biomarker in GD, it is important to know the CHIT1 genotype of each patient. In this study, ChT activity and CHIT1 genotype were evaluated in 33 GD type 1 patients under treatment in the state of Minas Gerais, Brazil, and compared to healthy controls. As expected, the enzyme activity was found to be higher in GD type 1 patients than in healthy subjects. Four patients had no ChT activity. Their genotype revealed three patients (9%) homozygous for dup24 allele and one patient with two polymorphisms in exon 11: G354R and a 4 bp deletion at the exon-intron 11 boundary (g.16993_16996delGAGT), the later described for the first time in literature. Two other patients with lower ChT activity presented a polymorphism in exon 4 (c.304G>A, p.G102S), without dup24 allele. In conclusion, this study demonstrated that ChT activity can be used for therapeutic monitoring in 82% of GD patients of the state of Minas Gerais, Brazil.

Competing interests: None declared

Co-senior authors: Ana Lúcia B Godard Eugênia R Valadares

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Aguilera B, Ghauharali-van der Vlugt K, Helmond MT et al (2003) Transglycosidase activity of chitotriosidase: improved enzymatic assay for the human macrophage chitinase. J Biol Chem 278:40911–40916

    Article  PubMed  CAS  Google Scholar 

  • Artieda M, Cenarro A, Gaña´n A et al (2003) Serum chitotriosidase activity is increases in subjects with atherosclerosis disease. Arterioscler Thromb Vasc Biol 23:1645–1652

    Article  PubMed  CAS  Google Scholar 

  • Ballou LR, Laulederkind SJ, Rosloniec EF, Raghow R (1996) Ceramide signaling and the immune response. Biochim Biophys Acta 1301:273–287

    Article  PubMed  Google Scholar 

  • Barone R, Di Gregorio F, Romeo MA, Schilirò G, Pavone L (1999) Plasma chitotriosidase activity in patients with β-thalassemia. Blood Cells Mol Dis 25:1–8

    Article  PubMed  CAS  Google Scholar 

  • Barone R, Simporé J, Malaguarnera L, Pignatelli S, Musumeci S (2003) Plasma chitotriosidase activity in acute Plasmodium falciparum malaria. Clin Chim Acta 331:79–85

    Article  PubMed  CAS  Google Scholar 

  • Beutler E, Grabowski GA (1995) Gaucher Disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 2641–2670

    Google Scholar 

  • Beutler E, Kuhl W (1970) The diagnosis of the adult type of Gaucher's disease and its carrier state by demonstration of deficiency of beta-glucosidase activity in peripheral blood leukocytes. J Lab Clin Med 76:747–755

    PubMed  CAS  Google Scholar 

  • Beutler E, Kuhl W, Trinidad F, Teplitz R, Nadler H (1971) Beta-glucosidase activity in fibroblasts from homozygotes and heterozygotes for Gaucher's disease. Am J Hum Genet 23:62–66

    PubMed  PubMed Central  CAS  Google Scholar 

  • Boot RG, Renkema GH, Verhoek M et al (1998) The human chitotriosidase gene: nature of inherited enzyme deficiency. J Biol Chem 273:25680–25685

    Article  PubMed  CAS  Google Scholar 

  • Boot RG, van Aqterberg TAE, van Aken BE et al (1999) Strong induction of members of the chitinase family of proteins in atherosclerosis chitotriosidase and human cartilage gp-39 expressed in lesion macrophages. Arterioscler Thromb Vasc Biol 19:687–694

    Article  PubMed  CAS  Google Scholar 

  • Boot RG, Hollak CEM, Verhoek M, Alberts C, Jonkers RE, Aerts JM (2010) Plasma chitotriosidase and CCL18 as surrogate markers for granulomatous macrophages in sarcoidosis. Clin Chim Acta 411:31–36

    Article  PubMed  CAS  Google Scholar 

  • Brady RO, Kanfer J, Shapiro D (1965) The metabolism of glucocerebrosides. I. Purification and properties of a glucocerebroside-cleaving enzyme from spleen tissue. J Biol Chem 240:39–43

    PubMed  CAS  Google Scholar 

  • Brinkman J, Wijburg FA, Hollak CEM et al (2005) Plasma chitotriosidase and CCL18: early biochemical surrogate markers in type B Niemann-Pick disease. J Inherit Metab Dis 28:13–20

    Article  PubMed  CAS  Google Scholar 

  • Bussink AP, Verhoek M, Vreede J et al (2009) Common G102S polymorphism in chitotriosidase differentially affects activity towards 4-methylumbelliferyl substrates. FEBS J 276:5678–5688

    Article  PubMed  CAS  Google Scholar 

  • Canudas J, Cenarro A, Civeira F et al (2001) Chitotriosidase genotype and serum activity in subjects with combined hyperlipidemia: effect of the lipid-lowering agents, atorvastatin and bezafibrate. Metabolism 50:447–450

    Article  PubMed  CAS  Google Scholar 

  • Choi EH, Zimmerman PA, Foster CB et al (2001) Genetic polymorphisms in molecules of innate immunity and susceptibility to infection with Wuchereria bancrofti in South India. Genes Immun 2:248–253

    Article  PubMed  CAS  Google Scholar 

  • Comabella M, Domínguez C, Rio J et al (2009) Plasma chitotriosidase activity in multiple sclerosis. Clin Immunol 131:216–222

    Article  PubMed  CAS  Google Scholar 

  • Cox T, Lachmann R, Hollak CEM et al (2000) Novel oral treatment of Gaucher’s disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis. Lancet 355:1481–1485

    Article  PubMed  CAS  Google Scholar 

  • Di Luca M, Romi R, Severini F et al (2007) High levels of human chitotriosidase hinder the formation of peritrophic membrane in anopheline vectors. Parasitol Res 100:1033–1039

    Article  PubMed  Google Scholar 

  • Di Rosa M, Musumeci M, Scuto A, Musumeci S, Malaguarnera L (2005) Effect of interferon-γ, interleukin-10, lipopolysaccharide and tumor necrosis factor-α on chitotriosidase synthesis in human macrophages. Clin Chem Lab Med 43:499–502

    PubMed  Google Scholar 

  • Froissart R (2006) Biomarqueurs actuels et futurs de la maladie de Gaucher. Rev Med Interne 27:S22–S25

    Article  PubMed  Google Scholar 

  • Gordon-Thomson C, Kumari A, Tomkins L et al (2009) Chitotriosidase and gene therapy for fungal infections. Cell Mol Life Sci 66:1116–1125

    Article  PubMed  CAS  Google Scholar 

  • Grace ME, Balwani M, Nazarenko I, Prakash-Cheng A, Desnick RJ (2007) Type 1 Gaucher disease: null and hypomorphic novel chitotriosidase mutations - implications for diagnosis and therapeutic monitoring. Hum Mutat 28:866–873

    Article  PubMed  CAS  Google Scholar 

  • Hollak CEM, van Weely S, van Oers MHJ, Aerts JMFG (1994) Marked elevation of plasma chitotriosidase activity: a novel hallmark of Gaucher disease. J Clin Invest 93:1288–1292

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Hollak CEM, Maas M, Aerts JM (2001) Clinically relevant therapeutic endpoints in type I Gaucher disease. J Inherit Metab Dis 24(Suppl):97–105

    Article  PubMed  CAS  Google Scholar 

  • Iyer A, van Eijk M, Silva E et al (2009) Increased chitotriosidase activity in serum of leprosy patients: association with bacillary leprosy. Clin Immunol 131:501–509

    Article  PubMed  CAS  Google Scholar 

  • Labadaridis J, Dimitriou E, Costalos C et al (1998) Serial chitotriosidase activity estimations in neonatal systemic candidiasis. Acta Paediatr 87:605

    Article  PubMed  CAS  Google Scholar 

  • Lee P, Waalen J, Crain K, Smargon A, Beutler E (2007) Human chitotriosidase polymorphisms G354R and A442V associated with reduced enzyme activity. Blood Cells Mol Dis 39:353–360

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Malaguarnera L, Simporè J, Prodi DA et al (2003) A 24-bp duplication in exon 10 of human chitotriosidase gene from the sub-Saharan to the Mediterranean area: role of parasitic diseases and environmental conditions. Genes Immun 4:570–574

    Article  PubMed  CAS  Google Scholar 

  • Malaguarnera L, Musumeci M, Di Rosa M, Scuto A, Musumeci S (2005) Interferon-gamma, tumor necrosis factor-alpha, and lipopolysaccharide promote chitotriosidase gene expression in human macrophages. J Clin Lab Anal 19:128–132

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Martins AM, Valadares ER, Porta G (2009) Recommendations on diagnosis, treatment, and monitoring for Gaucher Disease. J Pediatr 155:S10–18

    Article  PubMed  Google Scholar 

  • Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Mistry PK, Abrahamov A (1997) A practical approach to diagnosis and management of Gaucher's disease. BailIieres Clin Haematol 10:817–838

    Article  CAS  Google Scholar 

  • Ries M, Schaefer E, Luhrs T et al (2006) Critical assessment of chitotriosidase analysis in the rational laboratory diagnosis of children with Gaucher disease and Niemann–Pick disease type A/B and C. J Inherit Metab Dis 29:647–652

    Article  PubMed  CAS  Google Scholar 

  • Schoonhoven A, Rudensky B, Elstein D et al (2007) Monitoring of Gaucher patients with a novel chitotriosidase assay. Clin Chim Acta 381:136–139

    Article  PubMed  CAS  Google Scholar 

  • Sobreira E, Pires RF, Cizmarik M, Grabowski GA (2007) Phenotypic and genotypic heterogeneity in Gaucher disease type 1: a comparison between Brazil and the rest-of-the-world. Mol Genet Metab 90:81–86

    Article  PubMed  CAS  Google Scholar 

  • Souza MV, Krug BC, Picon PD, Schwartz IV (2010) Medicamentos de alto custo para doenças raras no Brasil: o exemplo das doenças lisossômicas. Cien Saude Colet 15:3443–3454

    Article  PubMed  Google Scholar 

  • van Eijk M, van Roomen CPAA, Renkema GH (2005) Characterization of human phagocyte-derived chitotriosidase, a component of innate immunity. Int Immunol 17:1505–1512

    Article  PubMed  Google Scholar 

  • Vellodi A, Foo Y, Cole TJ (2005) Evaluation of three biochemical markers in the monitoring of Gaucher disease. J Inherit Metab Dis 28:585–92

    Article  PubMed  CAS  Google Scholar 

  • Wajner A, Michelin K, Burin MG et al (2004) Biochemical characterization of chitotriosidase enzyme: comparison between normal individuals and patients with Gaucher and with Niemann-Pick diseases. Clin Biochem 37:893–897

    Article  CAS  PubMed  Google Scholar 

  • Wajner A, Michelin K, Burin MG et al (2007) Comparison between the biochemical properties of plasma chitotriosidase from normal individuals and from patients with Gaucher disease, GM1-gangliosidosis, Krabbe disease and heterozygotes for Gaucher disease. Clin Biochem 40:365–369

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank all the patients and control group for participation and for their cooperation, Prof. Luiz Alberto Cury, from Department of Physics – UFMG, Prof. Miguel Pocoví and Pilar Alfonso Palacín, from the Laboratorio de Bioquímica y Biología Celular y Molecular – University of Zaragoza, Spain, and Mrs. Annelie Schlenger, from the Biochemical Laboratory at the Children’s Hospital at University of Mainz, Germany, for the valuable discussions; the physicians of the Hematology Clinic at HC-UFMG for the good interaction with us in the laboratory; the Fundação de Amparo a Pesquisa do Estado de Minas Gerais for the financial support and master degree scholarship.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eugênia R Valadares .

Editor information

Editors and Affiliations

Additional information

Communicated by: Gregory M. Pastores

Appendices

Synopsis

Biochemical and molecular chitotriosidase profiles in Brazilian patients of Minas Gerais state, affected by Gaucher disease type 1, including the discovery of a new mutation in CHIT1 gene, are reported.

Conflict of Interest

None declared

Rights and permissions

Reprints and permissions

Copyright information

© 2012 SSIEM and Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Adelino, T.E.R. et al. (2012). Biochemical and Molecular Chitotriosidase Profiles in Patients with Gaucher Disease Type 1 in Minas Gerais, Brazil: New Mutation in CHIT1 Gene. In: Zschocke, J., Gibson, K.M., Brown, G., Morava, E., Peters, V. (eds) JIMD Reports – Case and Research Reports, 2012/6. JIMD Reports, vol 9. Springer, Berlin, Heidelberg. https://doi.org/10.1007/8904_2012_184

Download citation

  • DOI: https://doi.org/10.1007/8904_2012_184

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-35517-2

  • Online ISBN: 978-3-642-35518-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics